May 11
|
Exact Sciences Corporation (NASDAQ:EXAS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
|
May 10
|
Exact Sciences Corp (EXAS) Q1 2024 Earnings: Revenue Growth Amidst Increased Net Loss
|
May 10
|
UK NICE backs Exact’s Oncotype cancer genomic test
|
May 10
|
Exact Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
May 9
|
Exact Sciences Corporation (NASDAQ:EXAS) Q1 2024 Earnings Call Transcript
|
May 9
|
Exact Sciences (EXAS) Q1 Revenues Rise Y/Y, Gross Margin Down
|
May 9
|
Q1 2024 Exact Sciences Corp Earnings Call
|
May 9
|
Exact Sciences Corp (EXAS) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ...
|
May 9
|
Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight
|
May 9
|
Exact Sciences (EXAS) Q1 2024 Earnings Call Transcript
|
May 8
|
Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates
|
May 8
|
Exact Sciences Stock, A Cathie Wood Darling, Tumbles On Wide Quarterly Losses
|
May 8
|
Exact Sciences Announces First-Quarter 2024 Results
|
May 7
|
Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024
|
May 1
|
Techne (TECH) Q3 Earnings and Revenues Beat Estimates
|
May 1
|
Exact Sciences to Participate in May Investor Conference
|
Apr 24
|
Exact Sciences (EXAS) Stock Drops Despite Market Gains: Important Facts to Note
|
Apr 24
|
Here’s Why Baron Health Care Fund Reduced Exact Sciences Corporation (EXAS)
|
Apr 22
|
Should You Buy Exact Sciences (EXAS) Ahead of Q1 Earnings?
|
Apr 22
|
10 Best Performing Biotech ETFs in 2024
|